AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33093783 — intervention group
Group type: EXPERIMENTAL
Intervention: walk‐bike
Number of subjects: 23
Study 33093783 — intervention group
Group type: COMPARATOR
Intervention: standard care
Number of subjects: 23
Study 35108780 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-flow anesthesia (1 L/min)
Number of subjects: 104
Study 35108780 — intervention group
Group type: COMPARATOR
Intervention: High-flow anesthesia (2 L/min)
Number of subjects: 104
Study 33757957 — intervention group
Group type: EXPERIMENTAL
Intervention: Activate intervention
Number of subjects: 20
Study 32023606 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphate binder lanthanum carbonate
Number of subjects: 278
Study 32023606 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study 36253448 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich whey protein beverage (Resource®, Nestle Health Science)
Number of subjects: 78
Study 36253448 — intervention group
Group type: COMPARATOR
Intervention: Plain water
Number of subjects: 78
Study 35413793 — intervention group
Group type: EXPERIMENTAL
Intervention: Covariate constrained randomisation with adjusted analysis
Number of subjects: 0
Study 35413793 — intervention group
Group type: COMPARATOR
Intervention: Worst balanced allocations
Number of subjects: 0
Study 35413793 — intervention group
Group type: EXPERIMENTAL
Intervention: Covariate constrained randomisation
Number of subjects: 0
Study 35413793 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment for weakly prognostic covariates
Number of subjects: 0
Study 33788459 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-snake moxibustion combined with western medication (loperamide hydrochloride and bacillus licheniformis)
Number of subjects: 60
Study 33788459 — intervention group
Group type: COMPARATOR
Intervention: Simple medication (loperamide hydrochloride and bacillus licheniformis)
Number of subjects: 60
Study 32124570 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on the stages of change (home visits, telephone calls, group training sessions, delivery of printed material)
Number of subjects: 60
Study 32124570 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 60
Study 36199766 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 5386
Study 36199766 — intervention group
Group type: EXPERIMENTAL
Intervention: Random forest model
Number of subjects: 5386
Study 36199766 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme Gradient Boosting model
Number of subjects: 5386
Study 36199766 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model based on logistic regression
Number of subjects: 5386
Study 34009679 — intervention group
Group type: EXPERIMENTAL
Intervention: Grit-blasted with 110 µm alumina particles (GB)
Number of subjects: 63
Study 34009679 — intervention group
Group type: EXPERIMENTAL
Intervention: Polydopamine (PDA) coating
Number of subjects: 63
Study 34009679 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 63
Study 33139686 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program (EG)
Number of subjects: 39
Study 33139686 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program plus lifestyle education (ELG)
Number of subjects: 39
Study 33139686 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 39
Study 34915542 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 43
Study 34915542 — intervention group
Group type: COMPARATOR
Intervention: Sham needling
Number of subjects: 43
Study 33731305 — intervention group
Group type: EXPERIMENTAL
Intervention: PAL-HF intervention
Number of subjects: 1000
Study 33731305 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1000
Study 32757577 — intervention group
Group type: COMPARATOR
Intervention: Integrated Intervention for Dual Problems and Early Action (IIDEA), a 10-session manualized intervention that includes cognitive therapy and mindfulness practice.
Number of subjects: 0
Study 32757577 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment as usual (usual treatment plus scheduled assessments)
Number of subjects: 0
Study 33544914 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit Association Test (IAT)
Number of subjects: 180
Study 33544914 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-session narrative assignment
Number of subjects: 180
Study 32438787 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating sets (AST)
Number of subjects: 12
Study 32438787 — intervention group
Group type: COMPARATOR
Intervention: Straight sets (TRAD)
Number of subjects: 12
Study 35713688 — intervention group
Group type: EXPERIMENTAL
Intervention: AXR + BUS
Number of subjects: 56
Study 35713688 — intervention group
Group type: COMPARATOR
Intervention: AXR
Number of subjects: 56
Study 33591618 — intervention group
Group type: EXPERIMENTAL
Intervention: semaglutide 0.25 mg
Number of subjects: 104
Study 33591618 — intervention group
Group type: COMPARATOR
Intervention: dulaglutide 0.75 mg
Number of subjects: 104
Study 32717294 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 0
Study 32717294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36153634 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Cognitive Behavioral Therapy for Insomnia (OCBT-I) + Positive Airway Pressure (PAP) therapy
Number of subjects: 0
Study 36153634 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-delivered Cognitive Behavioral Therapy for Insomnia (TCBT-I)
Number of subjects: 0
Study 36153634 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) PAP + Sleep Hygiene Education
Number of subjects: 0
Study 33099898 — intervention group
Group type: EXPERIMENTAL
Intervention: nal-IRI+5-FU/LV
Number of subjects: 79
Study 33099898 — intervention group
Group type: COMPARATOR
Intervention: 5-FU/LV
Number of subjects: 79
Study 36470531 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily
Number of subjects: 6564
Study 36470531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6564
Study 33638096 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboxy therapy
Number of subjects: 28
Study 33638096 — intervention group
Group type: COMPARATOR
Intervention: Nd:YAG laser
Number of subjects: 28
Study 33268431 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention consisting of education of nursing staff, awareness raising and continuing medical education (CME) of general practitioners, and multicomponent non-pharmacological group intervention MAKS-mk+ (motor training, cognitive training, fall prevention)
Number of subjects: 0
Study 33268431 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 0
Study 36372062 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective Behavioral Strategies (PBS) measures (PBSS and SQ)
Number of subjects: 0
Study 36372062 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific PBS subscales
Number of subjects: 0
Study 34063068 — intervention group
Group type: EXPERIMENTAL
Intervention: NATUREN G® (synbiotic formulation)
Number of subjects: 0
Study 34063068 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35729493 — intervention group
Group type: EXPERIMENTAL
Intervention: GPMP (General Practice Management Plans)
Number of subjects: 905
Study 33108985 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training (PT)
Number of subjects: 116
Study 33726793 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural insights approach (n=31)
Number of subjects: 96
Study 33726793 — intervention group
Group type: COMPARATOR
Intervention: Standard outreach approach (n=65)
Number of subjects: 96
Study 32639946 — intervention group
Group type: EXPERIMENTAL
Intervention: Survival nomogram based on five clinicopathological features (race, AJCC stage, surgery for primary site, chemotherapy, tumor size)
Number of subjects: 794
Study 32639946 — intervention group
Group type: COMPARATOR
Intervention: AJCC staging system
Number of subjects: 794
Study 36241590 — intervention group
Group type: EXPERIMENTAL
Intervention: Early time-restricted eating (eTRE) with a daily 6-hour eating window
Number of subjects: 25
Study 36241590 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON) with a daily 16-hour eating window
Number of subjects: 25
Study 33516458 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy (n = 36)
Number of subjects: 66
Study 33516458 — intervention group
Group type: COMPARATOR
Intervention: Treatment waiting list (n = 30)
Number of subjects: 66
Study 35273107 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical Disc Arthroplasty (CDA)
Number of subjects: 397
Study 35273107 — intervention group
Group type: COMPARATOR
Intervention: Anterior Cervical Discectomy and Fusion (ACDF)
Number of subjects: 397
Study 33038066 — intervention group
Group type: EXPERIMENTAL
Intervention: High sodium meal (HSM; 1,495 mg Na+)
Number of subjects: 37
Study 33038066 — intervention group
Group type: COMPARATOR
Intervention: Low sodium meal (LSM; 138 mg Na+)
Number of subjects: 37
Study 33038066 — intervention group
Group type: EXPERIMENTAL
Intervention: High sodium meal (HSM)
Number of subjects: 37
Study 35502340 — intervention group
Group type: EXPERIMENTAL
Intervention: self‐adhering FCR
Number of subjects: 30
Study 35502340 — intervention group
Group type: EXPERIMENTAL
Intervention: fluoride‐releasing FCR
Number of subjects: 30
Study 35502340 — intervention group
Group type: EXPERIMENTAL
Intervention: microhybrid FCR
Number of subjects: 30
Study 36367444 — intervention group
Group type: COMPARATOR
Intervention: Habitat manipulation (temporary change to the environment)
Number of subjects: 16
Study 36367444 — intervention group
Group type: COMPARATOR
Intervention: Habitat manipulation with larviciding
Number of subjects: 16
Study 36367444 — intervention group
Group type: COMPARATOR
Intervention: Combination of habitat manipulation and permanent change (habitat modification)
Number of subjects: 16
Study 36367444 — intervention group
Group type: COMPARATOR
Intervention: Combination of manipulation and modification with larviciding
Number of subjects: 16
Study 37583921 — intervention group
Group type: EXPERIMENTAL
Intervention: Active craniocervical flexion (CCF) exercise (3 sets of 10 repetitions)
Number of subjects: 26
Study 37583921 — intervention group
Group type: EXPERIMENTAL
Intervention: Mulligan mobilisation (3 sets of 6-10 repetitions)
Number of subjects: 26
Study 33570517 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 sessions (3S)
Number of subjects: 36
Study 33570517 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 sessions (2S)
Number of subjects: 36
Study 33570517 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 session (1S)
Number of subjects: 36
Study 32434561 — intervention group
Group type: EXPERIMENTAL
Intervention: NNRTI-PDR testing
Number of subjects: 200
Study 32434561 — intervention group
Group type: EXPERIMENTAL
Intervention: NRTI resistance mutation (M184V)
Number of subjects: 200
Study 35986508 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium beta-hydroxybutyrate (BHB)
Number of subjects: 10
Study 35986508 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 10
Study 33839747 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretransplant bridging therapy
Number of subjects: 525
Study 33839747 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled disease (under bridging therapy)
Number of subjects: 525
Study 33839747 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with HCCs outside the Milan criteria (MC) downsized to within the MC
Number of subjects: 525
Study 32317673 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadmium concentration in plants (0, 10, and 100 mg kg‐1 soil)
Number of subjects: 3
Study 32317673 — intervention group
Group type: EXPERIMENTAL
Intervention: Mercury concentration in plants (0, 2, and 20 mg kg‐1 soil)
Number of subjects: 3
Study 32317673 — intervention group
Group type: EXPERIMENTAL
Intervention: Yield values of MxG
Number of subjects: 3
Study 32317673 — intervention group
Group type: EXPERIMENTAL
Intervention: Accumulation of cadmium in aboveground biomass
Number of subjects: 3
Study 32317673 — intervention group
Group type: EXPERIMENTAL
Intervention: Accumulation of mercury in aboveground biomass
Number of subjects: 3
Study 35840747 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose PTCy-ATG (20 mg/kg on day +3 and +4, 6 mg/kg ATG)
Number of subjects: 104
Study 35840747 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose ATG (10 mg/kg)
Number of subjects: 104
Study 32107343 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-salt diet
Number of subjects: 40
Study 32107343 — intervention group
Group type: COMPARATOR
Intervention: High-salt diet
Number of subjects: 40
Study 35906662 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care according to rehabilitation priorities adapted to post-COVID symptoms
Number of subjects: 1000
Study 35906662 — intervention group
Group type: COMPARATOR
Intervention: Control group: Patients of the post-COVID outpatient clinic without rehabilitation
Number of subjects: 1000
Study 32918100 — intervention group
Group type: EXPERIMENTAL
Intervention: Developmentally adapted cognitive processing therapy (D‐CPT)
Number of subjects: 85
Study 32918100 — intervention group
Group type: COMPARATOR
Intervention: Wait-list with treatment advice (WL/TA)
Number of subjects: 85
Study 33155236 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized antiplatelet therapy based on CYP2C19 genotype and platelet function (IA group)
Number of subjects: 89
Study 33155236 — intervention group
Group type: COMPARATOR
Intervention: Conventional antiplatelet therapy (CA group)
Number of subjects: 89
Study 36086822 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped-wedge cluster-randomized trial
Number of subjects: 54
Study 36086822 — intervention group
Group type: COMPARATOR
Intervention: Parallel-group cluster-randomized trial
Number of subjects: 54
Study 34441009 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant therapy
Number of subjects: 140
Study 34441009 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid therapy
Number of subjects: 140
Study 34441009 — intervention group
Group type: COMPARATOR
Intervention: Adverse events
Number of subjects: 140
Study 36060969 — intervention group
Group type: EXPERIMENTAL
Intervention: MET plus LIRA therapy
Number of subjects: 60
Study 36060969 — intervention group
Group type: COMPARATOR
Intervention: MET monotherapy
Number of subjects: 60
Study 36060969 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MET and COM
Number of subjects: 60
Study 33269975 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomegestrol acetate (NOMAc) 10 mg/day and transdermal 17-beta-estradiol (E2) 75 µg/week
Number of subjects: 202
Study 35109837 — intervention group
Group type: EXPERIMENTAL
Intervention: Local injection of tranexamic acid (TXA)
Number of subjects: 109
Study 35109837 — intervention group
Group type: COMPARATOR
Intervention: Drain clamping
Number of subjects: 109
Study 34762372 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp acupuncture electrical stimulation
Number of subjects: 54
Study 34762372 — intervention group
Group type: COMPARATOR
Intervention: Routine scalp acupuncture
Number of subjects: 54
Study 34134812 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 40
Study 34134812 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 34870114 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy combined with therapeutic neuroscience education (TNE)
Number of subjects: 31
Study 34870114 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy alone
Number of subjects: 31
Study 35920762 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab treatment
Number of subjects: 664
Study 32072618 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical trial evidence of a 'medication'
Number of subjects: 476
Study 32072618 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical trial evidence of a 'topical steroid'
Number of subjects: 476
Study 32072618 — intervention group
Group type: EXPERIMENTAL
Intervention: Anecdote of a 'medication'
Number of subjects: 476
Study 32072618 — intervention group
Group type: EXPERIMENTAL
Intervention: Anecdote of a 'topical steroid'
Number of subjects: 476
Study 32072618 — intervention group
Group type: EXPERIMENTAL
Intervention: Both clinical trial evidence and anecdote of a 'medication'
Number of subjects: 476
Study 32072618 — intervention group
Group type: EXPERIMENTAL
Intervention: Both clinical trial evidence and anecdote of a 'topical steroid'
Number of subjects: 476
Study 32072618 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctor's recommendation
Number of subjects: 476
Study 32072618 — intervention group
Group type: COMPARATOR
Intervention: No information on medication's efficacy or safety profile
Number of subjects: 476
Study 35101419 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose warfarin (target INR 2.0 to 2.5)
Number of subjects: 401
Study 35101419 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose warfarin (target INR 2.5 to 3.5)
Number of subjects: 401
Study 35101419 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose warfarin
Number of subjects: 401
Study 35101419 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose warfarin
Number of subjects: 401
Study 34472693 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 521
Study 34472693 — intervention group
Group type: COMPARATOR
Intervention: iGlar
Number of subjects: 521
Study 32919056 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (5-6 times weekly for 60 days)
Number of subjects: 22
Study 32919056 — intervention group
Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 22
Study 33977560 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline 0.5mg orally b.i.d.
Number of subjects: 33
Study 33977560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 32700461 — intervention group
Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 125
Study 32700461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 33397457 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care plus 1000 mg of nitazoxanide twice daily and 300/100 mg of atazanavir/ritonavir once daily orally
Number of subjects: 98
Study 33397457 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 98
Study 32315431 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist-shaped interdental brushes (WIBs)
Number of subjects: 20
Study 32315431 — intervention group
Group type: COMPARATOR
Intervention: Straight-shaped interdental brushes (SIBs)
Number of subjects: 20
Study 34953787 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide (N2O) cryoablation
Number of subjects: 60
Study 34953787 — intervention group
Group type: COMPARATOR
Intervention: Argon gas cryoablation
Number of subjects: 60
Study 34953787 — intervention group
Group type: EXPERIMENTAL
Intervention: Both N2O and argon cryoablation
Number of subjects: 60
Study 35477868 — intervention group
Group type: EXPERIMENTAL
Intervention: Identifiable data sharing for direct clinical care without explicit consent
Number of subjects: 29275
Study 35477868 — intervention group
Group type: EXPERIMENTAL
Intervention: Research sharing of de-identified data without explicit consent
Number of subjects: 29275
Study 35477868 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharing to NHS, academic institutions, and national research charities
Number of subjects: 29275
Study 35477868 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharing to profit-making companies
Number of subjects: 29275
Study 35477868 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharing to other companies
Number of subjects: 29275
Study 35477868 — intervention group
Group type: EXPERIMENTAL
Intervention: De-identified linkage to non-health data
Number of subjects: 29275
Study 35477868 — intervention group
Group type: EXPERIMENTAL
Intervention: Single NHS mechanism to choose uses of data
Number of subjects: 29275
Study 35477868 — intervention group
Group type: EXPERIMENTAL
Intervention: Support for data sharing during COVID-19
Number of subjects: 29275
Study 36254954 — intervention group
Group type: EXPERIMENTAL
Intervention: Manuka honey mouthrinse
Number of subjects: 80
Study 36254954 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocimum sanctum mouthrinse
Number of subjects: 80
Study 36254954 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcuma longa mouthrinse
Number of subjects: 80
Study 36254954 — intervention group
Group type: COMPARATOR
Intervention: 0.2% chlorhexidine mouthrinse
Number of subjects: 80
Study 34423474 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-hour feeding interval (Group A)
Number of subjects: 78
Study 34423474 — intervention group
Group type: COMPARATOR
Intervention: 3-hour feeding interval (Group B)
Number of subjects: 78
Study 34423474 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group A and Group B)
Number of subjects: 78
Study 33654379 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination analgesia (oral celebrex, pregabalin, and subcutaneous infiltration of ropivacaine)
Number of subjects: 93
Study 33654379 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine (only subcutaneous infiltration of ropivacaine)
Number of subjects: 93
Study 33654379 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 93
Study 32369191 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 25
Study 36288594 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg of dexamethasone
Number of subjects: 63
Study 36288594 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg of dexamethasone
Number of subjects: 63
Study 32307295 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) distraction
Number of subjects: 116
Study 32307295 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 116
Study 32307295 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 116
Study 32465030 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD at the time of LVAD implantation (n=350)
Number of subjects: 574
Study 32465030 — intervention group
Group type: COMPARATOR
Intervention: No ICD at the time of LVAD implantation (n=174)
Number of subjects: 574